Ardelyx (NASDAQ:ARDX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at Wedbush in a research note issued to investors on Friday, Benzinga reports. They currently have a $15.00 price target on the biopharmaceutical company’s stock. Wedbush’s price target would indicate a potential upside of 122.22% from the company’s previous close. […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) Director Richard W. Mott acquired 12,100 shares of the company’s stock in a transaction on Wednesday, May 22nd. The shares were acquired at an average cost of $4.99 per share, for a total transaction of $60,379.00. Following the completion of the acquisition, the director now owns […]
Delek US Holdings, Inc. (NYSE:DK – Free Report) – Investment analysts at Zacks Research reduced their Q2 2024 earnings per share (EPS) estimates for Delek US in a report released on Thursday, May 23rd. Zacks Research analyst R. Department now anticipates that the oil and gas company will earn $0.76 per share for the quarter, […]
Summit Financial LLC lessened its stake in Parker-Hannifin Co. (NYSE:PH – Free Report) by 4.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,663 shares of the industrial products company’s stock after selling 136 shares during the period. Summit Financial LLC’s holdings in […]
Cambridge Investment Research Advisors Inc. lowered its holdings in CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) by 13.0% during the first quarter, Holdings Channel.com reports. The firm owned 113,881 shares of the company’s stock after selling 17,018 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in CrowdStrike were worth $36,509,000 at the end […]